Gonadorelin monograph

Gonadorelin

Overview

Gonadorelin is the human hypothalamic gonadotropin-releasing hormone (GnRH), a decapeptide that triggers pituitary release of LH and FSH. In practice, it is used mainly as a diagnostic agent and historically in fertility-related contexts; it is not a mainstream bodybuilding drug, and performance-use claims are not well established. The evidence base for human pharmacokinetics is limited because the native peptide is rapidly cleared and short-acting.

Pharmacokinetics & Mechanism

• Class: Endogenous decapeptide hypothalamic hormone; GnRH agonist used diagnostically and in limited clinical settings
• Mechanism of action: Binds GnRH receptors on anterior pituitary gonadotrophs, activating the Gq/11-phospholipase C pathway, increasing intracellular calcium and stimulating pulsatile luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release. Continuous exposure can desensitize/downregulate the receptor and suppress gonadotropin output, but that is a feature of GnRH agonist therapy generally, not a performance-enhancement effect that is established for gonadorelin use.
• Target(s): GnRH receptor (GNRHR) on pituitary gonadotrophs; downstream LH/FSH secretion axis of the hypothalamic-pituitary-gonadal (HPG) pathway.
• Route(s) of administration: Primarily subcutaneous or intravenous injection in clinical/research use; not orally bioavailable. The DailyMed listing found is for CYSTORELIN, a veterinary gonadorelin product.
• Onset: Rapid, typically within minutes to tens of minutes for pituitary LH/FSH response after parenteral administration; exact onset depends on assay timing and dose. Not well established for bodybuilding use.
• Half-life: Very short plasma half-life in humans, generally reported in the range of only a few minutes; exact value varies by source and assay conditions. I did not find a high-quality FDA human label for gonadorelin itself in this search; available evidence supports that native GnRH is rapidly cleared rather than having a depot-like half-life. DAC/extended-release variants are not gonadorelin itself and should not be conflated with native gonadorelin.